Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XOPH5 Ointment for Lower Lid Steatoblepharon
NCT02230761Phase 2Completed
- Sponsor
- Topokine Therapeutics
- Start
- Sep 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of XAF5 in Steatoblepharon, sponsored by Topokine Therapeutics. Started Sep 2014; status: completed.
02
Drugs
XAF5
03
Conditions
Steatoblepharon
Beyond the preview
Go deeper on NCT02230761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02230761.